BST/TKDA (BST/TKDA)

Stuttgart Stock Exchange: BST/TKDA · EUR

€17.9

-0.10 (-0.6%)· Recorded snapshot

Market cap	57.2B
Revenue (ttm)	24.9B
Net income (ttm)	-880.1M
EPS (ttm)	-€0.29
Dividend	€0.46 (2.59%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 24.9B
Net income (ttm): -880.1M
EPS (ttm): -€0.29
Market cap: 57.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-2.3

P25 n/aP50 n/aP75 n/a

ROIC5.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.5%

Nasdaq Composite-2.4%

Dow Jones Industrial Average+1.8%

Russell 2000+1.8%

All BST/TKDA indicators

Market & fundamental data

Available fields

219

Groups with data

Currency

JPY

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Japan
Country code	DE
Earnings date	2026-10-29
Employees	47,029
Employees change	-1,826
Employees growth	-3.71%
Enterprise value	EUR 86.1B
Exchange	Stuttgart Stock Exchange
Financial currency	JPY
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1781
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	US8740602052
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Market cap	EUR 57.2B
Next earnings date	2026-10-29
Price	EUR 17.90
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bst/TKDA
Website	https://www.takeda.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	55.53x
Average P/E ratio (3Y)	60.13x
Average P/E ratio (5Y)	42.97x
Earnings yield	-1.64%
EV/EBIT	23.73x
EV/EBITDA	11.67x
EV/FCF	20.72x
EV/Sales	3.28x
FCF / EV yield	4.83%
FCF yield	7.26%
Industry forward P/E	17.38x
Industry P/E	28.22x
P/(FCF - SBC) ratio	15.25x
P/(OCF - SBC) ratio	12.09x
P/B ratio	1.41x
P/FCF ratio	13.78x
P/OCF ratio	11.15x
P/S ratio	2.3x
Price/EBITDA ratio	8.51x
Sector forward P/E	14.8x
Sector P/E	39.91x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	13.85%
EBITDA margin	27.05%
FCF margin	15.82%
Gross margin	64.47%
Operating margin	13.85%
Pretax margin	-2.82%
Profit margin	-3.54%
Profit per employee	EUR -18,714
Profitable quarters	1
Profitable years	11
Revenue per employee	EUR 528,883
ROA	2.69%
ROA (5Y)	2.57%
ROCE	4.96%
ROE	-2.26%
ROE (5Y)	2.21%
ROIC	5.13%
ROIC (5Y)	4.47%
SBC / revenue	1.61%
Tax / revenue	0.71%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	-9.83%
EPS growth years	1
FCF growth	-15.29%
FCF growth (Q)	-55.94%
FCF growth (QoQ)	162.06%
FCF growth 3Y	-2.82%
FCF growth 5Y	-3.33%
Gross profit growth	2.29%
Gross profit growth (Q)	12.63%
Gross profit growth 3Y	1.68%
Gross profit growth 5Y	5.05%
Net income growth (Q)	-8.89%
Net income growth years	1
OCF growth	-13.49%
OCF growth (Q)	-40.76%
OCF growth (QoQ)	71.24%
OCF growth 10Y	32.4%
OCF growth 3Y	-1.08%
OCF growth 5Y	-1.57%
Operating income growth	18.13%
Operating income growth (Q)	18.74%
Operating income growth 3Y	0.52%
Operating income growth 5Y	4.2%
Revenue growth	3.1%
Revenue growth (Q)	10.23%
Revenue growth (QoQ)	11.45%
Revenue growth 10Y	9.91%
Revenue growth 3Y	3.94%
Revenue growth 5Y	6.66%
Revenue growth quarters	3
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -979.5M
Depreciation and amortization	EUR 3.5B
EBIT	EUR 3.4B
EBITDA	EUR 6.7B
EPS	EUR -0.29
Financing cash flow	EUR -2.5B
Free cash flow	EUR 4.2B
Free cash flow minus SBC	EUR 3.8B
Gross profit	EUR 16B
Income taxes	EUR 177.1M
Investing cash flow	EUR -2.3B
Net borrowing	EUR -58.2M
Net cash flow	EUR 597.6M
Net income	EUR -880.1M
Operating cash flow minus SBC	EUR 4.7B
Operating income	EUR 3.4B
Revenue	EUR 24.9B
Stock-based compensation	EUR 400.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.09
Book value per share	EUR 25.75
Debt / EBITDA	4.26
Debt / equity	0.73
Debt / FCF	7.17
Goodwill	EUR 33.5B
Interest coverage	3.43
Long-term assets	EUR 66.4B
Long-term liabilities	EUR 27.9B
Net cash (debt)	EUR -27.3B
Net cash / market cap	-47.74%
Net debt / EBITDA	4.06
Net debt / equity	0.67
Net debt / FCF	6.58
Piotroski F-Score	4
Property, plant and equipment	EUR 12.2B
Shareholders' equity	EUR 40.7B
Tangible book value	EUR -9.3B
Tangible book value per share	EUR -5.86
Total assets	EUR 84.3B
Total cash	EUR 2.5B
Total debt	EUR 29.8B
Total liabilities	EUR 43.6B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.31
Current assets	EUR 17.9B
Current liabilities	EUR 15.7B
Current ratio	1.14
Inventory turnover	1.22
Net working capital	EUR 2.4B
Quick ratio	0.51
Working capital	EUR 2.1B
Working capital turnover	0.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.64%
Dividend growth	-11.16%
Dividend growth years	1
Dividend payment date	2026-07-06
Dividend payment years	4
Dividend payout frequency	Semi-Annual
Dividend per share	EUR 0.46
Dividend yield	2.59%
Ex-dividend date	2026-03-31
Last dividend	EUR 0.23
Shareholder yield	4.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 15.02
1D price change	-0.56%
1M price change	9.76%
1M total return	9.76%
1W price change	1.7%
1W total return	1.7%
1Y price change	45.16%
1Y return CAGR	50.16%
1Y total return	50.12%
20-day SMA	EUR 16.90
200-day SMA	EUR 15.03
3M price change	19.21%
3M total return	19.21%
50-day SMA	EUR 16.28
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 18.30
52-week high date	2026-10-26
52-week low	EUR 11.60
52-week low date	2025-11-05
5Y price change	42.86%
5Y return CAGR	10.26%
5Y total return	62.95%
6M price change	27.66%
6M total return	27.66%
All-time high	EUR 18.70
All-time high date	2019-12-17
All-time low	EUR 11.60
All-time low date	2025-11-05
Average true range (ATR)	EUR 0.42
Average volume	0
Change from 52-week high	-2.19%
Change from 52-week low	54.31%
Change from all-time high	-3.74%
Change from all-time low	55.17%
Change from open	-1.1%
Day's gap	0.56%
High price	EUR 18.20
Low price	EUR 17.90
Monthly RSI	64.77
Open price	EUR 18.10
Position in 52-week range	0%
Previous close	EUR 18.00
Price vs 150-day SMA	19.85%
Price vs 20-day SMA	6.54%
Price vs 200-day SMA	19.75%
Price vs 50-day SMA	10.59%
Relative volume	20
RSI	73.35
Sharpe ratio	1.35
Sortino ratio	2.15
Weekly RSI	72.87
YTD price change	37.41%
YTD total return	39.41%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.6B
Shares change (QoQ)	1.56%
Shares change (YoY)	-1.64%
Shares held by insiders	0.12%
Shares held by institutions	50.7%

Deeper analysis on BST/TKDA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BST/TKDA report

Is a complete BST/TKDA research report available?

No complete published report is available for bst/TKDA (BST/TKDA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

57.2B

Revenue (ttm)

24.9B

Net income (ttm)

-880.1M

EPS (ttm)

-€0.29

Dividend

€0.46 (2.59%)

Metric

Value

Amount currency

EUR

Country

Japan

Country code

Earnings date

2026-10-29

Employees

47,029

Employees change

-1,826

Employees growth

-3.71%

Enterprise value

EUR 86.1B

Exchange

Stuttgart Stock Exchange

Financial currency

JPY

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

March

Founded

1781

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

ISIN number

US8740602052

Last earnings date

2026-07-30

Last refreshed

2026-10-28

Market cap

EUR 57.2B

Next earnings date

2026-10-29

Price

EUR 17.90

Price currency

EUR

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-27

Symbol

bst/TKDA

Website

https://www.takeda.com

Metric

Value

Average P/E ratio (10Y)

55.53x

Average P/E ratio (3Y)

60.13x

Average P/E ratio (5Y)

42.97x

Earnings yield

-1.64%

EV/EBIT

23.73x

EV/EBITDA

11.67x

EV/FCF

20.72x

EV/Sales

3.28x

FCF / EV yield

4.83%

FCF yield

7.26%

Industry forward P/E

17.38x

Industry P/E

28.22x

P/(FCF - SBC) ratio

15.25x

P/(OCF - SBC) ratio

12.09x

P/B ratio

1.41x

P/FCF ratio

13.78x

P/OCF ratio

11.15x

P/S ratio

2.3x

Price/EBITDA ratio

8.51x

Sector forward P/E

14.8x

Sector P/E

39.91x

Metric

Value

EBIT margin

13.85%

EBITDA margin

27.05%

FCF margin

15.82%

Gross margin

64.47%

Operating margin

13.85%

Pretax margin

-2.82%

Profit margin

-3.54%

Profit per employee

EUR -18,714

Profitable quarters

Profitable years

Revenue per employee

EUR 528,883

ROA

2.69%

ROA (5Y)

2.57%

ROCE

4.96%

ROE

-2.26%

ROE (5Y)

2.21%

ROIC

5.13%

ROIC (5Y)

4.47%

SBC / revenue

1.61%

Tax / revenue

0.71%

Metric

Value

EPS growth (Q)

-9.83%

EPS growth years

FCF growth

-15.29%

FCF growth (Q)

-55.94%

FCF growth (QoQ)

162.06%

FCF growth 3Y

-2.82%

FCF growth 5Y

-3.33%

Gross profit growth

2.29%

Gross profit growth (Q)

12.63%

Gross profit growth 3Y

1.68%

Gross profit growth 5Y

5.05%

Net income growth (Q)

-8.89%

Net income growth years

OCF growth

-13.49%

OCF growth (Q)

-40.76%

OCF growth (QoQ)

71.24%

OCF growth 10Y

32.4%

OCF growth 3Y

-1.08%

OCF growth 5Y

-1.57%

Operating income growth

18.13%

Operating income growth (Q)

18.74%

Operating income growth 3Y

0.52%

Operating income growth 5Y

4.2%

Revenue growth

3.1%

Revenue growth (Q)

10.23%

Revenue growth (QoQ)

11.45%

Revenue growth 10Y

9.91%

Revenue growth 3Y

3.94%

Revenue growth 5Y

6.66%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

EUR -979.5M

Depreciation and amortization

EUR 3.5B

EBIT

EUR 3.4B

EBITDA

EUR 6.7B

EPS

EUR -0.29

Financing cash flow

EUR -2.5B

Free cash flow

EUR 4.2B

Free cash flow minus SBC

EUR 3.8B

Gross profit

EUR 16B

Income taxes

EUR 177.1M

Investing cash flow

EUR -2.3B

Net borrowing

EUR -58.2M

Net cash flow

EUR 597.6M

Net income

EUR -880.1M

Operating cash flow minus SBC

EUR 4.7B

Operating income

EUR 3.4B

Revenue

EUR 24.9B

Stock-based compensation

EUR 400.8M

Metric

Value

Altman Z-Score

1.09

Book value per share

EUR 25.75

Debt / EBITDA

4.26

Debt / equity

0.73

Debt / FCF

7.17

Goodwill

EUR 33.5B

Interest coverage

3.43

Long-term assets

EUR 66.4B

Long-term liabilities

EUR 27.9B

Net cash (debt)

EUR -27.3B

Net cash / market cap

-47.74%

Net debt / EBITDA

4.06

Net debt / equity

0.67

Net debt / FCF

6.58

Piotroski F-Score

Property, plant and equipment

EUR 12.2B

Shareholders' equity

EUR 40.7B

Tangible book value

EUR -9.3B

Tangible book value per share

EUR -5.86

Total assets

EUR 84.3B

Total cash

EUR 2.5B

Total debt

EUR 29.8B

Total liabilities

EUR 43.6B

Metric

Value

Asset turnover

0.31

Current assets

EUR 17.9B

Current liabilities

EUR 15.7B

Current ratio

1.14

Inventory turnover

1.22

Net working capital

EUR 2.4B

Quick ratio

0.51

Working capital

EUR 2.1B

Working capital turnover

0.07

Metric

Value

Buyback yield / dilution

1.64%

Dividend growth

-11.16%

Dividend growth years

Dividend payment date

2026-07-06

Dividend payment years

Dividend payout frequency

Semi-Annual

Dividend per share

EUR 0.46

Dividend yield

2.59%

Ex-dividend date

2026-03-31

Last dividend

EUR 0.23

Shareholder yield

4.22%

Metric

Value

150-day SMA

EUR 15.02

1D price change

-0.56%

1M price change

9.76%

1M total return

9.76%

1W price change

1.7%

1W total return

1.7%

1Y price change

45.16%

1Y return CAGR

50.16%

1Y total return

50.12%

20-day SMA

EUR 16.90

200-day SMA

EUR 15.03

3M price change

19.21%

3M total return

19.21%

50-day SMA

EUR 16.28

50-day SMA vs 200-day SMA

50over200

52-week high

EUR 18.30

52-week high date

2026-10-26

52-week low

EUR 11.60

52-week low date

2025-11-05

5Y price change

42.86%

5Y return CAGR

10.26%

5Y total return

62.95%

6M price change

27.66%

6M total return

27.66%

All-time high

EUR 18.70

All-time high date

2019-12-17

All-time low

EUR 11.60

All-time low date

2025-11-05

Average true range (ATR)

EUR 0.42

Average volume

Change from 52-week high

-2.19%

Change from 52-week low

54.31%

Change from all-time high

-3.74%

Change from all-time low

55.17%

Change from open

-1.1%

Day's gap

0.56%

High price

EUR 18.20

Low price

EUR 17.90

Monthly RSI

64.77

Open price

EUR 18.10

Position in 52-week range

Previous close

EUR 18.00

Price vs 150-day SMA

19.85%

Price vs 20-day SMA

6.54%

Price vs 200-day SMA

19.75%

Price vs 50-day SMA

10.59%

Relative volume

RSI

73.35

Sharpe ratio

1.35

Sortino ratio

2.15

Weekly RSI

72.87

YTD price change

37.41%

YTD total return

39.41%

Metric

Value

Float

1.6B

Shares change (QoQ)

1.56%

Shares change (YoY)

-1.64%

Shares held by insiders

0.12%

Shares held by institutions

50.7%

BST/TKDA (BST/TKDA)

Price

Financial snapshot

Fair-value bridge

Latest news · BST/TKDA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BST/TKDA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BST/TKDA

Frequently asked questions

BST/TKDA (BST/TKDA)

Price

Financial snapshot

Fair-value bridge

Latest news · BST/TKDA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BST/TKDA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BST/TKDA

Frequently asked questions